Ignite Creation Date:
2024-05-06 @ 6:08 PM
Last Modification Date:
2024-10-26 @ 2:42 PM
Study NCT ID:
NCT05551936
Status:
RECRUITING
Last Update Posted:
2024-06-05
First Post:
2022-09-19
Brief Title:
A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
Sponsor:
Vaishalee Kenkre
Organization:
Big Ten Cancer Research Consortium
Organization Data
Organization:
Big Ten Cancer Research Consortium
Class:
OTHER
Study ID:
BTCRC LYM20-463
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vaishalee Kenkre
Lead Sponsor Class:
OTHER
Responsible Party:
Vaishalee Kenkre
Responsible Party Title:
Sponsor Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Big Ten Cancer Research Consortium
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Wisconsin Madison | OTHER |
| Epizyme Inc | INDUSTRY |